At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 enrolled
Drug / intervention
robotic surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Robotic Surgery on Systemic Immune-inflammation Index in Gastric Cancer Patients
In Brief
An observational study evaluating robotic surgery for Gastric Cancer. Completed, enrolled 300 participants across 1 site.
Detailed Summary
Robotic surgery has been gaining attention because of the physical and metabolic morbidity of the conventional open technique.The systemic immune-inflammation index(SII) has emerged as a recent and more reliable biomarker.In our single-center retrospective cohort study, the investigators investigate SII in robotic gastrectomy in order to show the advantageous effect on immune system which the investigators think as the first study in the literature.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastric Cancer
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartDec 2023
Primary CompletionDec 2024
Study CompletionJan 2025
First PostedFeb 2025
TodayJul 2026
First PostedFeb 6, 2025
Enrollment StartDec 1, 2023
Primary CompletionDec 31, 2024
Study CompletionJan 1, 2025
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 1.4 years ago
Interventions
robotic surgeryprocedure
minimally invasive surgery